Pages that link to "Q22252835"

The following pages link to Transgenic rodent models of Parkinson’s disease (Q22252835):

Displaying 15 items.

• (Q24654626) (redirect page) (← links)
• Mouse Genetic Models of Human Brain Disorders (Q26752246) (← links)
• Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson's disease (Q34970932) (← links)
• Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin (Q35359238) (← links)
• Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease. (Q35679526) (← links)
• Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1 (Q36158367) (← links)
• PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice (Q36218704) (← links)
• Inflammation in neurodegenerative diseases (Q37766302) (← links)
• Review article Genetically modified animals for use in research and biotechnology (Q37777106) (← links)
• Genetic mouse models of Parkinson's disease The state of the art. (Q37796009) (← links)
• Parkinson's disease mouse models in translational research (Q37874160) (← links)
• Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models (Q38044434) (← links)
• The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed (Q38200738) (← links)
• Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test (Q39696572) (← links)
• Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson's Disease. (Q55085565) (← links)